Showing results (411-420 of 6,499) with videos related to
Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|February 9, 2000
Neutrophils are cytotoxic and growth-inhibiting for neuroblastoma cells with an anti-GD2 antibody but, without cytotoxicity, can be growth-stimulatingR L Chen, C P Reynolds, R C SeegerCancer Immunology, Immunotherapy : CII|July 6, 2000
Antitumor effect of heat-killed Lactobacillus plantarum L-137 through restoration of impaired interleukin-12 production in tumor-bearing miceS Murosaki, K Muroyama, Y Yamamoto, et al.Cancer Immunology, Immunotherapy : CII|July 6, 2000
Initiation of humoral and cellular immune responses in patients with refractory Hodgkin's disease by treatment with an anti-CD16/CD30 bispecific antibodyC Renner, F Hartmann, W Jung, et al.Cancer Immunology, Immunotherapy : CII|April 15, 1999
Effect of local interleukin-2 treatment on spontaneous tumours of different immunogenic strengthL Fiszer-Maliszewska, W Den Otter, M MordarskiCancer Immunology, Immunotherapy : CII|April 15, 1999
Autoantibodies against the tumour-associated antigen GA733-2 in patients with colorectal carcinomaS Mosolits, U Harmenberg, U Rudén, et al.Cancer Immunology, Immunotherapy : CII|October 24, 2000
A bispecific single-chain antibody directed against EpCAM/CD3 in combination with the cytokines interferon alpha and interleukin-2 efficiently retargets T and CD3+CD56+ natural-killer-like T lymphocytes to EpCAM-expressing tumor cellsD Flieger, P Kufer, I Beier, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1989
Comparative effect of rat and fetal calf serum on measurement of the natural tumoricidal activity of rat lymphocytes, macrophages and polymorphonuclear cellsD Reisser, C Fady, H Pelletier, et al.Cancer Immunology, Immunotherapy : CII|September 29, 2017
Daunorubicin conjugated with alpha-fetoprotein selectively eliminates myeloid-derived suppressor cells (MDSCs) and inhibits experimental tumor growthNikolai N Belyaev, Nurshat Abdolla, Yuliya V Perfilyeva, et al.Cancer Immunology, Immunotherapy : CII|October 9, 2017
Tumor-infiltrating immune cells as potential biomarkers predicting response to treatment and survival in patients with metastatic melanoma receiving ipilimumab therapyTímea Balatoni, Anita Mohos, Eszter Papp, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1987
Inhibition of tumor metastasis of Lewis lung carcinoma in C57BL/6 mice by intrapleural administration of Lactobacillus caseiT Matsuzaki, T YokokuraPageof 650